Intravenous Fosfomycin Pharmacokinetics Study

NCT03910673 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Bacterial Infection
Multiple-drug Resistance
Pathogen Resistance

Interventions

DRUG: Fosfomycin disodium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)